RIPTACs: Harnessing Cooperative PPIs to Drive Stable Ternary Complexes & Clinical Promise

• Hypothesis driven approach to achieve novel induced proximity pairings with unique mechanism-of-action
• Targeting a cooperative ternary complex to achieve exquisitely selective functional impact in oncology
• Driving translational progress through in vitro, in vivo, and toxicology studies, to emerging clinical data that highlight RIPTACs’ therapeutic promise

Speakers:

Kyle Eastman

VP

Halda Therapeutics, LLC